A Forbes article outlines the various costs associated with obtaining GLP-1 drugs in 2026, noting that one in eight US adults currently uses these medications. The report details that most users do not pay the full retail price, with options ranging from $25 copays to the full $1,349 retail cost. AI
RANK_REASON Article provides analysis and cost breakdown of existing drugs, not a new release or significant industry event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →